Our team

---

Compleo Advisors brings together senior leaders across rare disease strategy, creative, advocacy engagement, and activation. Each member of our team has deep experience working within the rare disease ecosystem—inside agencies, alongside biotech teams, and in partnership with advocacy organizations.

We assemble the right team for each engagement, intentionally matched to the needs, stage, and scope of the work. That means you receive focused, experienced leadership—not layered structures or unnecessary overhead.

Our model allows us to remain nimble while bringing the depth and perspective required to move complex rare disease work forward. We’re always happy to share team bios and introduce relevant members once we’ve had the opportunity to understand your specific goals.

“Compleo exists to fill a critical gap in rare disease.
I see early-stage companies advancing meaningful science without the commercial readiness work happening early enough — not because they don’t value it, but because lean teams and limited resources force hard trade-offs. At the same time, I see advocacy organizations stepping into expanded roles in research, partnership, and funding — without the strategic and creative support to operationalize their influence.

Both are mission-driven. Both are operating with urgency. Both deserve experienced support that fits their stage.

I built Compleo to provide senior, hands-on partnership that moves at the pace of emerging organizations — operating nimbly within real resource constraints and delivering outsourced strategic and creative leadership where it’s needed most. Not just plans, but execution. Not just ideas, but forward motion. In rare disease, progress can’t wait — and neither can the work that supports it.”
 

— Kristin Marvin Keller, Founder